Clinical Trials Advisor
March 15, 2012
| Vol.
17 No.
6
FDA Cautions Against Use of Phthalates as Drug Excipients
The FDA is warning drugmakers to avoid using two types of phthalates as excipients because of safety concerns, according to a new draft guidance.
This article is viewable by subscribers only. To view this article, please select an option below.
|